Data Mining Framework for Discovering and Clustering Phenotypes of Atypical Diabetes

Author:

Parikh Hemang M1ORCID,Remedios Cassandra L1ORCID,Hampe Christiane S2,Balasubramanyam Ashok3ORCID,Fisher-Hoch Susan P4,Choi Ye Ji5,Patel Sanjeet6ORCID,McCormick Joseph B4,Redondo Maria J7,Krischer Jeffrey P1ORCID

Affiliation:

1. Health Informatics Institute, Morsani College of Medicine, University of South Florida , Tampa, FL 33612 , USA

2. Department of Medicine, University of Washington , Seattle, WA 98195 , USA

3. Division of Diabetes, Endocrinology and Metabolism, Baylor College of Medicine , Houston, TX 77030 , USA

4. The University of Texas Health Science Center at Houston School of Public Health, Brownsville Regional Campus , Brownsville, TX 78520 , USA

5. The University of Texas Rio Grande Valley School of Medicine, Edinburg Campus , Edinburg, TX 78539 , USA

6. The Keck School of Medicine of the University of Southern California , Los Angeles, CA 90033 , USA

7. Section of Diabetes and Endocrinology, Texas Children's Hospital, Baylor College of Medicine , Houston, TX 77030 , USA

Abstract

AbstractContextSome individuals present with forms of diabetes that are “atypical” (AD), which do not conform to typical features of either type 1 diabetes (T1D) or type 2 diabetes (T2D). These forms of AD display a range of phenotypic characteristics that likely reflect different endotypes based on unique etiologies or pathogenic processes.ObjectiveTo develop an analytical approach to identify and cluster phenotypes of AD.MethodsWe developed Discover Atypical Diabetes (DiscoverAD), a data mining framework, to identify and cluster phenotypes of AD. DiscoverAD was trained against characteristics of manually classified patients with AD among 278 adults with diabetes within the Cameron County Hispanic Cohort (CCHC) (Study A). We then tested DiscoverAD in a separate population of 758 multiethnic children with T1D within the Texas Children's Hospital Registry for New-Onset Type 1 Diabetes (TCHRNO-1) (Study B).ResultsWe identified an AD frequency of 11.5% in the CCHC (Study A) and 5.3% in the pediatric TCHRNO-1 (Study B). Cluster analysis identified 4 distinct groups of AD in Study A: cluster 1, positive for the 65 kDa glutamate decarboxylase autoantibody (GAD65Ab), adult-onset, long disease duration, preserved beta-cell function, no insulin treatment; cluster 2, GAD65Ab negative, diagnosed at age ≤21 years; cluster 3, GAD65Ab negative, adult-onset, poor beta-cell function, lacking central obesity; cluster 4, diabetic ketoacidosis (DKA)–prone participants lacking a typical T1D phenotype. Applying DiscoverAD to the pediatric patients with T1D in Study B revealed 2 distinct groups of AD: cluster 1, autoantibody negative, poor beta-cell function, lower body mass index (BMI); cluster 2, autoantibody positive, higher BMI, higher incidence of DKA.ConclusionDiscoverAD can be adapted to different datasets to identify and define phenotypes of participants with AD based on available clinical variables.

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

United States Department of Health and Human Services

National Institutes of Health

National Center on Minority Health and Health Disparities

National Center for Advancing Translational Sciences

DHHS Centers for Disease Control and Prevention

Center for Clinical and Translational Sciences

National Institutes of Health Clinical and Translational

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3